TAZ Antikörper (Internal Region)

Produktnummer ABIN7224612

Der Kaninchen Polyklonal anti-TAZ Antikörper wird verwendet zum Nachweis von TAZ in Proben von Human und Maus. Er wurde validiert für WB und ELISA.

Kurzübersicht für TAZ Antikörper (Internal Region) (ABIN7224612)

Target: TAZ (Tafazzin (TAZ))

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TAZ Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Produktdetails anti-TAZ Antikörper

Bindungsspezifität: Internal Region

Verwendungszweck: Rabbit Anti-Tafazzin Polyclonal Antibody

Spezifität: Tafazzin Polyclonal Antibody detects endogenous levels of Tafazzin protein.

Aufreinigung: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogen: Synthesized peptide derived from the Internal region of human Tafazzin

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,ELISA 1:5000,Not yet tested in other applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Haltbarkeit: 12 months

Details zu TAZ

Target: TAZ (Tafazzin (TAZ))

Andere Bezeichnung: Tafazzin

Hintergrund: TAZ, EFE2, G4.5, Tafazzin, Protein G4.5TAZ (tafazzin) encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in TAZ have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.

Molekulargewicht: 33kD

Gen-ID: 6901

UniProt: Q16635